The genetic predisposition to adverse outcome after trauma.

Technological advances and shorter rescue times have allowed early and effective resuscitation after trauma and brought attention to the host response to injury. Trauma patients are at risk of progressive organ dysfunction from what appears to be an uncontrolled immune response. The availability of improved techniques of molecular diagnosis has allowed investigation of the role of genetic variations in the inflammatory response to post-traumatic complications and particularly to sepsis. This review examines the current evidence for the genetic predisposition to adverse outcome after trauma. While there is evidence supporting the involvement of different polymorphic variants of genes in determining the post-traumatic course and the development of complications, larger-scale studies are needed to improve the understanding of how genetic variability influences the responses to post-traumatic complications and pharmacotherapy.

[1]  J. Hazelzet,et al.  Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Newman,et al.  APOE polymorphism is associated with risk of severe sepsis in surgical patients* , 2005, Critical care medicine.

[3]  D. Christiani,et al.  −308GA and TNFB polymorphisms in acute respiratory distress syndrome , 2005, European Respiratory Journal.

[4]  R. Wunderink,et al.  Genetic susceptibility to pneumonia. , 2005, Clinics in chest medicine.

[5]  Jacob E. Wang Can single nucleotide polymorphisms in innate immune receptors predict development of septic complications in intensive care unit patients? , 2005, Critical Care Medicine.

[6]  K. Walley,et al.  Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults* , 2005, Critical care medicine.

[7]  A. Medford,et al.  Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome , 2005, Thorax.

[8]  K. Walley,et al.  The association of interleukin 6 haplotype clades with mortality in critically ill adults. , 2005, Archives of internal medicine.

[9]  A. Gordon,et al.  TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study , 2004, Genes and Immunity.

[10]  J. Hunt,et al.  TLR4 and TNF-α polymorphisms are associated with an increased risk for severe sepsis following burn injury , 2004, Journal of Medical Genetics.

[11]  G. O’Keefe,et al.  Genetic determinants of the inflammatory response , 2004, Current opinion in critical care.

[12]  A. Ekkernkamp,et al.  ASSOCIATION OF INTERLEUKIN-10 PROMOTER POLYMORPHISM WITH THE INCIDENCE OF MULTIPLE ORGAN DYSFUNCTION FOLLOWING MAJOR TRAUMA: RESULTS OF A PROSPECTIVE PILOT STUDY , 2004, Shock.

[13]  P. Zabel,et al.  Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. , 2003, American journal of respiratory and critical care medicine.

[14]  N. Stassen,et al.  IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. , 2003, Surgery.

[15]  P. Giannoudis,et al.  Current concepts of the inflammatory response after major trauma: an update. , 2003, Injury.

[16]  G. O’Keefe,et al.  Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis. , 2003, American journal of respiratory and critical care medicine.

[17]  J. Verhoef,et al.  Lipoprotein metabolism in patients with severe sepsis , 2003, Critical care medicine.

[18]  B. Dahlbäck,et al.  Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states. , 2003, Hematology/oncology clinics of North America.

[19]  N. Webster,et al.  Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients* , 2003, Critical care medicine.

[20]  Jonathan Cohen The immunopathogenesis of sepsis , 2002, Nature.

[21]  F. Schade,et al.  Tumor Necrosis Factor Gene Polymorphisms, Leukocyte Function, and Sepsis Susceptibility in Blunt Trauma Patients , 2002, Clinical and Vaccine Immunology.

[22]  S. Humphries,et al.  Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. , 2002, American journal of respiratory and critical care medicine.

[23]  N. Stassen,et al.  Interferon-γ gene polymorphisms and the development of sepsis in patients with trauma * , 2002 .

[24]  S. Dzik Early goal-directed therapy in the treatment of severe sepsis and septic shock , 2002 .

[25]  G. O’Keefe,et al.  The G-->A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. , 2002, The Journal of trauma.

[26]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[27]  E. Lonn,et al.  The T-786→C Mutation in Endothelial Nitric Oxide Synthase Is Associated With Hypertension , 2002, Hypertension.

[28]  K. Sullivan,et al.  An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus , 2002, Human mutation.

[29]  Wei Huang,et al.  Sequence variations in the mu‐opioid receptor gene (OPRM1) associated with human addiction to heroin , 2002, Human mutation.

[30]  S. DeKosky,et al.  Genetic variation in α1-antichymotrypsin and its association with Alzheimer’s disease , 2002, Human Genetics.

[31]  R. Cantor,et al.  Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. , 2002, Chest.

[32]  W. Thomson,et al.  Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica. , 2002, The Journal of rheumatology.

[33]  C. Frevert,et al.  High and low inflammatory response phenotypes in 101 normal human subjects. , 2002, Chest.

[34]  S. Nadel Helping to understand studies examining genetic susceptibility to sepsis , 2002, Clinical and experimental immunology.

[35]  F. Tsai,et al.  Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan , 2002, Acta obstetricia et gynecologica Scandinavica.

[36]  G. Assmann,et al.  Effect of the interleukin-6 promoter polymorphism (−174 G/C) on the incidence and outcome of sepsis , 2002, Critical care medicine.

[37]  Jeffrey I. Weitz,et al.  Characterization of a Mouse Model for Thrombomodulin Deficiency , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[38]  P. Barie,et al.  Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients , 2001, Critical care medicine.

[39]  B. Beutler,et al.  The sole gateway to endotoxin response: how LPS was identified as Tlr4, and its role in innate immunity. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[40]  T. V. van Berkel,et al.  Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality , 2001, The Journal of Biological Chemistry.

[41]  G. Rothe,et al.  Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis , 2001, Critical care medicine.

[42]  D. Laskowitz,et al.  Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response , 2001, Journal of Neuroimmunology.

[43]  F. Stüber,et al.  Gender differences in sepsis: genetically determined? , 2000, Shock.

[44]  D. Arveiler,et al.  Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[45]  W. Ricart,et al.  Interleukin-6 gene polymorphism and insulin sensitivity. , 2000, Diabetes.

[46]  S. D'alfonso,et al.  New polymorphisms in the IL-10 promoter region , 2000, Genes and Immunity.

[47]  F. Stüber,et al.  Relation of a TNF gene polymorphism to severe sepsis in trauma patients. , 1999, Annals of surgery.

[48]  D. Purdie,et al.  Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa , 1999, Hepatology.

[49]  A. Hoeft,et al.  Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. , 1999, Critical care medicine.

[50]  P. Woo,et al.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[51]  P. Holt,et al.  A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. , 1999, American journal of respiratory cell and molecular biology.

[52]  M. Netea,et al.  Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. , 1999, Journal of lipid research.

[53]  F. Schade,et al.  Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. , 1999, Cytokine.

[54]  K. Werdan,et al.  ASSOCIATION OF SERUM TUMOR NECROSIS FACTOR LEVELS WITH DECREASE OF CHOLESTEROL DURING SEPTIC SHOCK , 1998, Shock.

[55]  A. Daugherty,et al.  Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.

[56]  R. Westendorp,et al.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Giannoudis,et al.  Trauma and the immune response , 1998, Journal of the Royal Society of Medicine.

[58]  R. Dickson,et al.  Stimulation of inflammatory markers after blunt trauma , 1998, The British journal of surgery.

[59]  G. Regel,et al.  Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. , 1998, The Journal of trauma.

[60]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[61]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[62]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[63]  P. Reitsma,et al.  Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. , 1996, Cytokine.

[64]  J. Carcillo,et al.  Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. , 1996, Critical care medicine.

[65]  G. Siest,et al.  Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. , 1996, Journal of lipid research.

[66]  S. Anttila,et al.  Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. , 1995, Gene.

[67]  P. Guillou,et al.  Biological variation in the development of sepsis after surgery or trauma , 1993, The Lancet.

[68]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[69]  P. Jeggo,et al.  The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14–q21, in the region of the IL-1α and IL-1β loci , 1992 .

[70]  J. E. Carceller American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[71]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[72]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[73]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[74]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[75]  A. Bowcock,et al.  Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. , 1989, Nucleic acids research.

[76]  E. Abraham Host defense abnormalities after hemorrhage, trauma, and burns. , 1989, Critical care medicine.

[77]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[78]  M. Yamada,et al.  Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. , 1985, Nucleic acids research.

[79]  L. J. Eldik,et al.  A dual role for apolipoprotein E in neuroinflammation , 2007, Journal of Molecular Neuroscience.

[80]  D. Dries Genetic predisposition for a compromised immune system after multiple trauma , 2007 .

[81]  D. Christiani,et al.  Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. , 2004, Chest.

[82]  David T. Huang,et al.  Early goal-directed therapy. , 2004, Critical care medicine.

[83]  G. Gallagher,et al.  A polymorphic dinucleotide repeat in the human IL-10 promoter , 2004, Immunogenetics.

[84]  D. Kunz,et al.  Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. , 2003, Critical care medicine.

[85]  N. Stassen,et al.  Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma. , 2002, Surgery.

[86]  J. Buxbaum,et al.  Association between a GABRB3 polymorphism and autism , 2002, Molecular Psychiatry.

[87]  O. Migita,et al.  An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia , 2002, Molecular Psychiatry.

[88]  S. DeKosky,et al.  Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. , 2002, Human genetics.

[89]  Dechang Chen,et al.  [Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients]. , 2002, Zhonghua yi xue za zhi.

[90]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[91]  S. D'alfonso,et al.  Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. , 2000, Arthritis and rheumatism.

[92]  I. Udalova,et al.  -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. , 1995, Journal of inflammation.

[93]  F. Pociot,et al.  A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. , 1992, European journal of clinical investigation.

[94]  L. Shingarova,et al.  Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome. , 1986, Cold Spring Harbor symposia on quantitative biology.

[95]  PHILIP,et al.  The Journal of Bone and Joint Surgery. , 1950, Annals of the Royal College of Surgeons of England.